Published in Curr Drug Targets on November 01, 2000
Adenosine: an old drug newly discovered. Anesthesiology (2009) 1.99
Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood (2008) 1.79
Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface. Trends Cardiovasc Med (2008) 1.36
PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J Clin Invest (2008) 1.35
New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. Curr Drug Targets (2001) 1.07
Dynamic purine signaling and metabolism during neutrophil-endothelial interactions. Purinergic Signal (2005) 0.88
The calcium activated nucleotidases: A diverse family of soluble and membrane associated nucleotide hydrolyzing enzymes. Purinergic Signal (2006) 0.87
Invited Lectures : Overviews Purinergic signalling: past, present and future. Purinergic Signal (2006) 0.75
New developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. Curr Drug Targets (2001) 0.75
Ischemic Cerebroprotection Conferred by Myeloid Lineage-Restricted or Global CD39 Transgene Expression. Circulation (2017) 0.75
Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet (1997) 4.92
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med (1999) 4.44
Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med (1998) 3.54
Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem (1996) 2.79
The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet (2000) 2.59
Barriers to xenotransplantation. Nat Med (1995) 2.44
Fetal effects of combined spinal-epidural vs epidural labour analgesia: a prospective, randomised double-blind study. Anaesthesia (2014) 1.99
Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis. BJOG (2014) 1.91
Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol (2001) 1.89
Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates. Transplantation (2000) 1.88
Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signal (2005) 1.81
Transgenic overexpression of CD39 protects against renal ischemia-reperfusion and transplant vascular injury. Am J Transplant (2010) 1.74
Adaptation of the maternal heart in pregnancy. Br Heart J (1992) 1.70
P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem (2001) 1.63
Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am J Transplant (2010) 1.55
Hydralazine boluses for the treatment of severe hypertension in pre-eclampsia. Br J Obstet Gynaecol (1994) 1.42
Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta (2010) 1.40
Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. Br J Pharmacol (2008) 1.30
Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur J Neurosci (2000) 1.29
Prediction of the small for gestational age infant: which ultrasonic measurement is best? Obstet Gynecol (1992) 1.29
Isolated CD39 expression on CD4+ T cells denotes both regulatory and memory populations. Am J Transplant (2009) 1.27
Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae. J Biol Chem (2000) 1.26
CD39 modulates endothelial cell activation and apoptosis. Mol Med (2000) 1.25
Delayed xenograft rejection. Immunol Today (1996) 1.23
Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes. Thromb Haemost (1999) 1.20
Results of gal-knockout porcine thymokidney xenografts. Am J Transplant (2009) 1.19
Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol (2006) 1.17
Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis. Biochem Biophys Res Commun (1998) 1.15
The differential expression of myometrial connexin-43, cyclooxygenase-1 and -2, and Gs alpha proteins in the upper and lower segments of the human uterus during pregnancy and labor. J Clin Endocrinol Metab (1999) 1.15
Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab (2000) 1.10
Maternal uniparental disomy for chromosome 2 in association with confined placental mosaicism for trisomy 2 and severe intrauterine growth retardation. Prenat Diagn (1996) 1.10
Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Biochemistry (1999) 1.10
Reply to: 'the discovery of a new class of synaptic transmitters in smooth muscle fifty years ago and amelioration of coronary artery thrombosis'. Acta Physiol (Oxf) (2013) 1.09
Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation (1998) 1.09
Identification and characterization of a novel hepatic canalicular ATP diphosphohydrolase. J Biol Chem (2000) 1.08
Rejection of cardiac xenografts transplanted from alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant (2008) 1.08
Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol (2001) 1.07
Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation (1997) 1.07
Hemeoxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. FASEB J (2000) 1.06
Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation (1999) 1.06
Xenotransplantation. Adv Immunol (2001) 1.05
Noise exposure induces up-regulation of ecto-nucleoside triphosphate diphosphohydrolases 1 and 2 in rat cochlea. Neuroscience (2004) 1.04
Xenogeneic endothelial cells activate human prothrombin. Transplantation (1997) 1.03
Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival. Transplantation (2000) 1.03
Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction. FASEB J (2001) 1.01
A novel mammalian wnt gene, WNT8B, shows brain-restricted expression in early development, with sharply delimited expression boundaries in the developing forebrain. Hum Mol Genet (1998) 1.01
Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience (2006) 1.00
Helicobacter pylori infection stimulates plasminogen activator inhibitor 1 production by gastric epithelial cells. Infect Immun (2008) 1.00
Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev (1994) 1.00
Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation (2001) 1.00
Does antenatal pelvic dilation predict renal scarring? Arch Dis Child Fetal Neonatal Ed (2005) 0.99
A 15-year experience of injection sclerotherapy in adult patients with extrahepatic portal venous obstruction. Ann Surg (1994) 0.98
Modification of vascular responses in xenotransplantation: inflammation and apoptosis. Nat Med (1997) 0.98
Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF. J Immunol (1997) 0.98
Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor. Blood (1997) 0.98
Anti-CD154 monoclonal antibody and thromboembolism. Transplantation (2001) 0.98
Lysophosphatidic acid activates nuclear factor kappa B and induces proinflammatory gene expression in endothelial cells. Thromb Haemost (1999) 0.97
Randomized trial of bolus phenylephrine or ephedrine for maintenance of arterial pressure during spinal anaesthesia for Caesarean section. Br J Anaesth (1996) 0.97
Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta (2008) 0.97
Hematopoietic stem cell markers are expressed by ductal plate and bile duct cells in developing human liver. Hepatology (1995) 0.96
Localization of plasma membrane bound NTPDases in the murine reproductive tract. Histochem Cell Biol (2009) 0.96
Mitochondrial recoupling: a novel therapeutic strategy for cancer? Br J Cancer (2011) 0.95
Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. Mol Med (1999) 0.94
Haemodynamic changes during the early puerperium. Br Med J (Clin Res Ed) (1987) 0.94
Renal and cardiac endothelial heterogeneity impact acute vascular rejection in pig-to-baboon xenotransplantation. Am J Transplant (2009) 0.93
Prediction of perinatal morbidity at term in small fetuses: comparison of fetal growth and Doppler ultrasound. Br J Obstet Gynaecol (1994) 0.93
Immunological similarity between the 170 kD amoebic adherence glycoprotein and human beta 2 integrins. Lancet (1993) 0.93
Identification of fetal growth retardation: comparison of Doppler waveform indices and serial ultrasound measurements of abdominal circumference and fetal weight. Obstet Gynecol (1993) 0.93
Suppression of ATP diphosphohydrolase/CD39 in human vascular endothelial cells. Biochemistry (1999) 0.92
Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis. Blood Cells Mol Dis (2001) 0.92
Secretion of angiogenic growth factors by villous cytotrophoblast and extravillous trophoblast in early human pregnancy. Placenta (2010) 0.92
Apyrase administration prolongs discordant xenograft survival. Transplantation (1996) 0.92
Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy. Am J Physiol (1999) 0.92
CD39 modulates IL-1 release from activated endothelial cells. Biochem Biophys Res Commun (2000) 0.92
Third trimester fetal growth and umbilical venous blood concentrations of IGF-1, IGFBP-1, and growth hormone at term. Arch Dis Child Fetal Neonatal Ed (1995) 0.91
Expression of human thrombomodulin cofactor activity in porcine endothelial cells. Transplantation (1998) 0.91
Inhibition of platelet aggregation in baboons: therapeutic implications for xenotransplantation. Xenotransplantation (2000) 0.91
Xenotransplantation: endothelial cell activation and beyond. Transplant Proc (1995) 0.91
Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol (2001) 0.90
Loss of rat glomerular ATP diphosphohydrolase activity during reperfusion injury is associated with oxidative stress reactions. Thromb Haemost (1996) 0.90
Molecular incompatibilities in hemostasis between swine and men--impact on xenografting. Ann Transplant (2001) 0.90
The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2. Eur J Biochem (2001) 0.90
Regulation of monocyte tissue factor activity by allogeneic and xenogeneic endothelial cells. Thromb Haemost (1998) 0.90
CD39 as a caveolar-associated ectonucleotidase. Biochem Biophys Res Commun (1999) 0.90
Effect of low oxygen concentrations on trophoblast-like cell line invasion. Placenta (2006) 0.90
Spatio-temporal expression of the trans-acting splicing factors SF2/ASF and heterogeneous ribonuclear proteins A1/A1B in the myometrium of the pregnant human uterus: a molecular mechanism for regulating regional protein isoform expression in vivo. J Clin Endocrinol Metab (2000) 0.89
NTPDase and 5' ecto-nucleotidase expression profiles and the pattern of extracellular ATP metabolism in the Walker 256 tumor. Biochim Biophys Acta (2007) 0.89
Transforming growth factor beta expression in human placenta and placental bed during early pregnancy. Placenta (2002) 0.89
Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantation. Am J Transplant (2002) 0.89
Porcine hematopoietic cell xenotransplantation in nonhuman primates is complicated by thrombotic microangiopathy. Bone Marrow Transplant (2001) 0.89
Decision support for women choosing mode of delivery after a previous caesarean section: a developmental study. Patient Educ Couns (2008) 0.89
Anti-inflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice. Am J Transplant (2010) 0.89
Decidual leucocyte populations in early to late gestation normal human pregnancy. J Reprod Immunol (2009) 0.89
Women's perception of future risk following pregnancies complicated by preeclampsia. Hypertens Pregnancy (2012) 0.88
An investigation of fetal growth using serial ultrasound data. Ultrasound Obstet Gynecol (1993) 0.88
Control of IBMIR in neonatal porcine islet xenotransplantation in baboons. Am J Transplant (2014) 0.87
Esophageal atresia in the Northern Region Congenital Anomaly Survey, 1985-1997: prenatal diagnosis and outcome. Am J Obstet Gynecol (2000) 0.87
Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus. J Med Virol (2000) 0.87
Anti-E in pregnancy. BJOG (2000) 0.87